Hyperthermia inhibits the proliferation and invasive ability of mouse malignant melanoma through TGF-β(1)

Area of Science:

• Oncology
• Biomedical Engineering
• Molecular Biology

Background:

• Tumor cell invasion involves basement membrane degradation mediated by proteinases like matrix metalloproteinases (MMPs).
• Transforming growth factor-beta 1 (TGF-β(1)) is a critical cytokine influencing the balance of MMPs and their inhibitors.
• Understanding the molecular mechanisms of hyperthermia in melanoma is crucial for developing effective therapies.

Purpose of the Study:

• To investigate the therapeutic effects of hyperthermia on aggressive malignant melanoma.
• To elucidate the molecular mechanism of hyperthermia, focusing on the TGF-β(1) pathway.

Main Methods:

• Real-time PCR (RT-PCR) and western blotting were used to analyze TGF-β(1) and Smad4 expression in B16F10 melanoma cells post-heat treatment.
• Time-dependent expression changes were monitored for 24 hours.
• Magnetic fluid hyperthermia (MFH) was applied in vivo to melanoma mouse models to assess tumor growth and TGF-β(1) expression.

Main Results:

• Hyperthermia significantly suppressed the proliferation and invasive capabilities of B16F10 melanoma cells.
• In vivo studies showed reduced tumor growth rates in melanoma mouse models following MFH.
• A notable decline in TGF-β(1) protein expression was observed after hyperthermia treatment in both cell cultures and animal models.

Conclusions:

• Hyperthermia demonstrates therapeutic potential against aggressive malignant melanoma by inhibiting tumor cell proliferation and invasion.
• The observed therapeutic effects are associated with modulation of the TGF-β(1) signaling pathway.
• Changes in the TGF-β(1) pathway induced by hyperthermia represent a significant component of its molecular mechanism in melanoma treatment.